CD39 and CD161 Modulate Th17 responses in Crohn's disease

Journal of Immunology

Volumn 193, Issue 7, 2014, Pages 3366-3377

  Bai, Aiping ^a   Moss, Alan ^a   Kokkotou, Efi ^a   Usheva, Anny ^a   Sun, Xiaofeng ^a   Cheifetz, Adam ^a   Zheng, Yi ^b   Longhi, Maria Serena ^a   Gao, Wenda ^c   Wu, Yan ^a   Robson, Simon C ^a  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Antagen Institute for Biomedical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD161 ANTIGEN; CD39 ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; NUCLEOTIDE; SPHINGOMYELIN PHOSPHODIESTERASE; STAT3 PROTEIN; STEROID; TUMOR NECROSIS FACTOR ANTIBODY; APYRASE; BIOLOGICAL MARKER; INTERLEUKIN 17; LEUKOCYTE ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY B; STAT3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CATALYSIS; CD4+ T LYMPHOCYTE; CELL INTERACTION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; ENZYME ACTIVITY; FEMALE; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; IN VITRO STUDY; LAMINA PROPRIA; LYMPHOCYTE DIFFERENTIATION; MALE; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; TH2 CELL; YOUNG ADULT; CLINICAL TRIAL; IMMUNOLOGY; INFLAMMATION; MIDDLE AGED; MUCOSA; PATHOLOGY;

ADULT; AGED; ANTIGENS, CD; APYRASE; BIOLOGICAL MARKERS; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-17; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; SIGNAL TRANSDUCTION; SPHINGOMYELIN PHOSPHODIESTERASE; STAT3 TRANSCRIPTION FACTOR; TH17 CELLS;

EID: 84907192427     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400346     Document Type: Article

References (52)

1. Constant, S. L., and K. Bottomly. 1997. Induction of Th1 and T h2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15: 297-322.
2. Ouyang, W., J. K. Kolls, and Y. Zheng. 2008. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28: 454-467.
3. Abraham, C., and J. H. Cho. 2009. Inflammatory bowel disease. N. Engl. J. Med. 361: 2066-2078.
4. Brand, S. 2009. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 58: 1152-1167.
5. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27: 485-517.
6. Xavier, R. J., and D. K. Podolsky. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
7. McAleer, J. P., and J. K. Kolls. 2011. Mechanisms controlling Th17 cytokine expression and host defense. J. Leukoc. Biol. 90: 263-270.
8. Strober, W., and I. J. Fuss. 2011. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140: 1756-1767.
9. Abraham, C., and J. Cho. 2009. Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm. Bowel Dis. 15: 1090-1100.
10. Bai, A., N. Lu, Y. Guo, Z. Liu, J. Chen, and Z. Peng. 2009. All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J. Leukoc. Biol. 86: 959-969.
11. Stockinger, B., and M. Veldhoen. 2007. Differentiation and function of Th17 T cells. Curr. Opin. Immunol. 19: 281-286.
12. Chen, Z., C. M. Tato, L. Muul, A. Laurence, and J. J. O'Shea. 2007. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum. 56: 2936-2946.
13. van Beelen, A. J., Z. Zelinkova, E. W. Taanman-Kueter, F. J. Muller, D. W. Hommes, S. A. Zaat, M. L. Kapsenberg, and E. C. de Jong. 2007. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27: 660-669.
14. Cos mi, L., R. De Palma, V. Santarlasci, L. Maggi, M. Capone, F. Frosali, G. Rodolico, V. Querci, G. Abbate, R. Angeli, et al. 2008. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precu rsor. J. Exp. Med. 205: 1903-1916.
15. Kleinschek, M. A., K. Boniface, S. Sadekova, J. Grein, E. E. Murphy, S. P. Turner, L. Raskin, B. Desai,W. A. Faubion, R. deWaal Malefyt, et al. 20 09. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J. Exp. Med. 206: 525-534.
16. Dwyer, K. M., S. Deaglio, W. Gao, D. Friedman, T. B. Strom, and S. C. Robson. 2007. CD39 and control of cellular immune responses. Purinergic Signal. 3: 171-180.
17. Deaglio, S., K. M. Dwyer, W. Gao, D. Friedman, A. Usheva, A. Erat, J. F. Chen, K. Enjyo ji, J. Linden, M. Oukka, et al. 2007. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204: 1257-1265.
18. Zhou, Q., J. Yan , P. Putheti, Y. Wu, X. Sun, V. Toxavidis, J. Tigges, N. Kassam, K. Enjyoji, S. C. Robson, et al. 2009. Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations. Am. J. Transplant . 9: 2303-2311.
19. Dwyer, K. M., D. Hanidziar, P. Putheti, P. A. Hill, S. Pommey, J. L. McRae, A. Winterhalter, G. Doherty, S. Deaglio, M. Koulmanda, et al. 2010. Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am. J. Transplant. 10: 2410-2420.
20. Schuchman, E. H. 2010. Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease. FEBS Lett. 584: 1895 -1900.
21. Sakata, A., T. Ochiai, H. Shimeno, S. Hikishima, T. Yokomatsu, S. Shibuya, A. Toda, R. Eyanagi, and S. Soeda. 2007. Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodiuminduced colitis in mice. Immunol ogy 122: 54-64.
22. Egwuagu, C. E. 2009. STAT3 in CD4+ T helper cell differentiation and inflammatory diseases. Cytokine 47: 149-156.
23. Chalmin, F., G. Mignot, M. Bruchard, A. Chevriaux, F. Vé gran, A. Hichami, S. Ladoire, V. Derangère, J. Vincent, D. Masson, et al. 2012. Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotida se expression. Immunity 36: 362-373.
24. Delgoffe, G. M., K. N. Pollizzi, A. T. Waickman, E. Heikamp, D. J. Meyers, M. R. Horton, B. Xiao, P. F. Worley, and J. D. Powell. 2011. The kin ase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 12: 295-303.
25. Bai, A., N. Lu, Y. Guo, J. Chen, and Z. Liu. 2009. Modulation of inflammatory response via alpha2-adrenoceptor blockade in acute murine colitis. Clin. Exp. Immunol. 156: 353-362.
26. Sun, X., Y. Wu, W. Gao, K. Enjyoji, E. Csizmadia, C. E. Müller, T. Murakami, and S. C. Robson. 2010. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice. Gastroenterology 139: 1030-1040.
27. Wiegmann, K., S. Schütze, T. Machleidt, D. Witte, and M. Krönke. 1994. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78: 1005-1015.
28. Bian, S., X. S un, A. Bai, C. Zhang, L. Li, K. Enjyoji,W. G. Junger, S. C. Robson, and Y. Wu. 2013. P2X7 integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death. PLoS ONE 8: e60184.
29. Astier, A. L., G. Beriou, T. M. Eisenhaure, S. M. Anderton, D. A. Hafler, and N. Hacohen. 2010. RNA interference screen in primary human T cells reveals FLT3 as a modulator of IL-10 levels. J. Immunol. 184: 685-693.
30. Annunziato, F., L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Filì, S. Ferri, F. Frosali, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204: 1849-1861.
31. Shen, H., J. C. Goodall, and J. S. Hill Gaston. 2009. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 60: 1647-1656.
32. Shi, L. Z., R. Wang, G. Huang, P. Vogel, G. Neale, D. R. Green, and H. Chi. 2011. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint fo r the differentiation of TH17 and Treg cells. J. Exp. Med. 208: 1367-1376.
33. Michalek, R. D., V. A. Gerriets, S. R. Jacobs, A. N. Macintyre, N. J. MacIver, E. F. Mason, S. A. Sullivan, A. G. Nichols, and J. C. Rathmell. 2011. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186: 3299-3303.
34. Cair ns, R. A., I. S. Harris, and T. W. Mak. 2011. Regulation of cancer cell metabolism. Nat. Rev. Cancer 11: 85-95.
35. Vander Heiden M.G.,L.C. Cantley,C.B. Thompson. 2009. Understanding theWarburg effect: the metabolic requirements of cell proliferation. Science. 324:1029-1033.
36. Harvey, R. F., and J. M. Bradshaw. 1980. A simple i ndex of Crohn's-disease activity. Lancet 1: 514.
37. Sakuraba, A., T. Sato, N. Kamada, M. Kitazume, A. Sugita, and T. Hibi. 2009. Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. Gastroenterology 137: 1736-1745.
38. Veny, M., M. Esteller, E. Ricart, J. M. Piqué, J. Panés, and A. Salas. 2010. Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients. Aliment. Pharmacol. Ther. 31: 561-572.
39. Colgan, S. P., H. K. Eltzschig, T. Eckle, and L. F. Thompson. 2006. Physiological roles for ecto-59-nucleotidase (CD73). Purinergic Signal. 2: 351-360.
40. Franco, R., A. Valenzuela, C. Lluis, and J. Blanco. 1998. Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes. Immunol. Rev. 161: 27-42.
41. Pozo, D., M. Valé s-Gómez, N. Mavaddat, S. C. Williamson, S. E. Chisholm, and H. Reyburn. 2006. CD161 (human NKR-P1A) signaling in N K cells involves the activation of acid sphingomyelinase. J. Immunol. 176: 2397-2406.
42. Yamamura, T. 2007. Interleukin 17-producing T-helper cells and autoimmune diseases: time for a paradigm shift? Curr. Rheumatol. Rep. 9: 93-95.
43. Mucida, D., Y. Park, G. Kim, O. Turovskaya, I. Scott, M. Kronenberg, and H. Cheroutre. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260.
44. Atarashi, K., J. Nishimura, T. Shima, Y. Umesaki, M. Yamamoto, M. Onoue, H. Yagita, N. Ishii, R. Evans, K. Honda, and K. Takeda. 2 008. ATP drives lamina propria T(H)17 cell differentiation. Nature 455: 808-812.
45. Doherty, G. A., A. Bai, D. Hanidziar, M. S. Longhi, G. O. Lawlor, P. Putheti, E. Csizmadia, M. Nowak, A. S. Cheifetz, A. C. Moss, and S. C. Robson. 2012. CD73 is a phenotypic marker of effector memory Th17 cells in inflammatory bowel disease. Eur. J. Immunol. 42: 3062-3072.
46. Bikman, B. T., and S. A. Summers. 2011. Ceramides as modulators of cellular and whole-body metabolism. J. Clin. Invest. 121: 4222-4230.
47. Zhang, Y., X. Li, K. A. Becker, and E. Gulbins. 2009. Ceramide-e nriched membrane domains-structure and function. Biochim. Biophys. Acta 1788: 178-183.
48. Wu, Y., X. Sun, E. Kaczmarek, K. M. Dwyer, E. Bianchi, A. Usheva, and S. C. Robson. 2006. RanBPM associates with CD39 and modulates ectonucleotidase activity. Biochem. J. 396: 23-30.
49. Murrin, L. C., and J. N. Talbot. 2007. RanBPM, a scaffolding protein in the immune and nervous systems. J. Neuroimmune Pharmacol. 2: 290-295.
50. Sun, Q., X. Chen, J. Ma, H. Peng, F. Wang, X. Zha, Y. Wa ng, Y. Jing, H. Yang, R. Chen, et al. 2011. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proc. Natl. Acad. Sci. USA 108: 4129-4134.
51. von Bismarck, P., C. F. Wistädt, K. Klemm, S. Winoto-Morbach, U. Uhlig, S. Schütze, D. Adam, B. Lachmann, S. Uhlig, and M. F. Krause. 2008. Improved pulmonary function by acid sphingom yelinase inhibition in a newborn piglet lavage model. Am. J. Respir. Crit. Care Med. 177: 1233-1241.
52. Bauer, J., G. Liebisch, C. Hofmann, C. Huy, G. Schmitz, F. Obermeier, and J. Bock. 2009. Lipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression. PLoS ONE 4: e7197.